Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
7 drugs in development
By Therapeutic Area
top 4
R&D Momentum
82/100
Pipeline Velocity
55/100
Trial Completion Rate
66/100
Pipeline Concentration
23/100
Pipeline Freshness
70/100
Strategic Signals
Activity
Last 14 days
OurChild: A Health IT Solution to Reduce Minority Health Disparities
Person-Centered Quality Measurement and Management (QM2) in a System for Addictions Treatment in New York State (Project 3)
Paradoxical Lucidity in Severe End-Stage Dementia
Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II)
Elucidating Neural Mechanisms and Sex Differences in Response to Mindfulness Based Stress Reduction in Generalized Anxiety Disorder
Optimal Dosing of IC-Green for Visualization of Rotator Cuff Vascularity Using Advanced Imaging Modality Arthroscopy: A Prospective, Randomized Trial
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR) Trial
Natural History and Genetics of VEXAS Syndrome and Related Autoinflammatory Syndromes
Human Hippocampal Oscillations During Visuomotor Exploration
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)